Regulation of endothelial cell myosin light chain phosphorylation and permeability by vanadate

Journal of Cellular Biochemistry

Volumn 70, Issue 1, 1998, Pages 141-155

  Gilbert McClain, Lydia I ^a   Verin, Alexander D ^a   Shi, Shu ^a   Irwin, Robert P ^a   Garcia, Joe G N ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Endothelial cell; MLCK; Permeability; Tyrosine phosphatase; Vanadate

Indexed keywords

GENISTEIN; MYOSIN LIGHT CHAIN; PROTEIN TYROSINE PHOSPHATASE; THROMBIN; VANADIC ACID;

ANIMAL CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CATTLE; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE CONTRACTILITY; TARGET CELL;

ANIMALS; CALCIUM; CATTLE; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; THROMBIN; VANADATES;

EID: 0032127329     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980701)70:1<141::AID-JCB14>3.0.CO;2-S     Document Type: Article

References (39)

1. Abebe W, Agrawal DK (1995): Role of tyrosine kinases in norepinephrine-induced contraction of vascular smooth muscle. J Cardiovasc Pharmacol 26:153-159.
2. Adelstein RS, Klee CB (1981): Purification and characterization of smooth muscle myosin light chain kinase. J Biol Chem 14:7501-7509.
3. Akiyama T, Ogawara H (1991): Use and specificity of genistein as inhibitor of protein tyrosine kinases. Methods Enzymol 201:362-370.
4. Akiyama T, Ishida J, Nakawawa S, Ogawara H, Watanabe S, Itoh N, Shibuva M, Fukami Y (1987): Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595.
5. 2+ sensitivity for contraction of smooth muscle. Can J Physiol Pharmacol 72:1434-1439.
6. Filipeanu CM, Brailou E, Huburez G, Slatineanu S, Ovidiu B, Dimitrie DB (1995): Multiple effects of tyrosine kinase inhibitors on vascular smooth muscle contraction. Eur J Pharmacol 281:29-35.
7. Fox AAL, Borchard U, Neumann M (1993): Effects of vanadate on isolated vascular tissue: Biochemical and functional investigations. J Cardiovasc Pharmacol 5:309-316.
8. Garcia JGN, Natarajan V (1992): Signal transduction in pulmonary endothelium: Implication for lung vascular dysfunction. Chest 102:592-607.
9. Garcia JGN, Schaphorst KL (1995): Regulation of endothelial cell gap formation and paracellular permeability. J Invest Med 43:117-126.
10. Garcia JGN, Birnboim AS, Bizios R, Del Vecchio PJ, Fenton JW, Malik AB (1986): Thrombin-induced increases in albumin clearance across cultured endothelial monolayers. J Cell Physiol 128:96-104.
11. Garcia JGN, Davis HW, Patterson CE (1995): Regulation of endothelial cell gap formation and barrier dysfunction: Role of myosin light chain phosphorylation. J Cell Physiol 163:510-522.
12. Garcia JGN, Lazar V, Gilbert-McClain LI, Gallagher PJ, Verin AD (1997a): Myosin light chain kinase in endothelium: Molecular cloning and regulation. Am J Respir Cell Mol Biol 16:487-491.
13. Garcia JGN, Schaphorst KL, Shi S, Verin AD, Hart CM, Callahan KS, Patterson CE (1997b): Mechanisms of ionomycin-induced endothelial cell barrier dysfuction. Am J Physiol 72:865-873.
14. 2+-EGTA association constant for temperature and ionic strength. Cell Calcium 12:279-287.
15. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
16. ++ responses: Structure-activities studies. J Pharmacol Exp Ther 271: 677-682.
17. Jin N, Siddiqui RA, Rhoades R, English D (1996): Communications between the MLCK and tyrosine kinase signaling pathways in smooth muscle cells. Am J Physiol 271: H1348-H1355.
18. Johansen JW, Ingebritsen TS (1986): Phosphorylation and inactivation of protein phosphatase 1 by pp60 v-src. Proc Natl Acad Sci U S A 83:207-211.
19. Kamm KE, Stull JT (1985): The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol 25:593-620.
20. Kolodney M, Wysolmerski R (1992): Isomeric contraction by fibroblasts and endothelial cells in tissue culture: A quantitative study. J Cell Biol 117:73-82.
21. Laemmli UK (1970): Cleavage of structural proteins during the assembly of the head of bacterio-phage T4. Nature 227:680-685.
22. lck by the CD45 phosphotyrosine phosphatase. Proc Natl Acad Sci U S A 86:6302-6306.
23. Patterson CE, Rhoades RA, Garcia JGN (1992): Evans Blue-albumin binding as a new marker of transendothelial macromolecule permeability. J Appl Physiol 72:865-873.
24. Patterson CE, Davis HW, Schaphorst KL, Garcia JGN (1994): Mechanisms of cholera toxin prevention of thrombin and PMA-induced endothelial cell barrier dysfunction. Microvasc Res 48:212-235.
25. Sandirasegarane L, Gopalakrishnan V (1995): Vanadate increases cytosolic free calcium in rat aortic smooth muscle cells.Life Sci 56:PL 169-174.
26. Sauro MD, Sudakow R, Burns S (1996): In vivo effects of angiotensin II on vascular smooth muscle contraction and blood pressure are mediated through a protein tyrosine kinase-dependent mechanism. J Pharmacol Exp Ther 277:1744-1750.
27. Schnittler HJ, Wilke A, Cress T, Suttorp N, Drenckhahn D (1990): Role of actin and myosin in the control of paracellular permeability in pig, rat, and human vascular endothelium. J Physiol 431:379-401.
28. Semenchuk LA, DiSalvo J (1995): Receptor-activated increases in intracellular calcium and protein tyrosine phosphorylation in vascular smooth muscle cells. FEBS Lett 370:127-130.
29. Shi S, Verin AD, Gilbert-McClain LI, Schaphorst KL, Patterson CE, Natarajan V, Garcia JGN (1998): Tyrosine phosphorylation modulates endothelial cell contraction and J barrier function. Endothelium.
30. Shimada, Shimamura K, Sunano S (1986): Effects of sodium vanadate on various types of vascular smooth muscles. Blood Vessels 23:113-124.
31. Stephanie WW, Cheol HY, George C, Webb RC (1996): Serotonin stimulates protein tyrosyl phosphorylation and vascular contraction via tyrosine kinase. J Vase Res 33:288-298.
32. Tirupathi C, Malik AB, Del Vecchil P, Keese CR, Giaever I (1992): Electrical method for detection of endothelial cell shape change in real time: Assessment of endothelial barrier function. Proc Natl Acad Sci U S A 89:7919-7923.
33. Tonks NK (1993): Protein tyrosine phosphatases. Semin Cell Biol 4:373-454.
34. Treuner M, Bohmer FD, Schulze W, Petuchov SP, Grosse R (1992): Limited selectivity of a synthetic erbstain derivative for tyrosine kinase and cell growth inhibition. Biochem Int 26:617-625.
35. Verin AD, Patterson CE, Day MA, Garcia JGN (1995): Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities. Am J Physiol 269:L99-L108.
36. Verin AD, Gilbert-McClain LI, Patterson CE, Garcia JGN (1998): Biochemical regulation of the non-muscle myosin light chain kinase isoform in bovine endothelium. Am J Respir Cell Mol Biol.
37. Walton KM, Dixon JE (1993): Protein tyrosine kinases. Annu Rev Biochem 62:101-120.
38. Wang JYJ, McWhirter JR (1994): Tyrosine-kinase-dependent signaling pathways. Trends Cardiovasc Med 4:264-270.
39. Wysolmerski RB, Lagunoff D (1990): Involvement of myosin light-chain kinase in endothelial cell retraction. Proc Natl Acad Sci U S A 87:16-20.